Position in INCY
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$435,755
+$37,157 QoQ
Shares Held
3,844
-9.2% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.08%
of 13F equity value
Holder Rank
#545
of 849 holders
Holding Since
Mar 2024
10 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in INCY Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Advisory Alpha, LLC holds $2,276,517 across 6 Biotechnology names. INCY ranks #3 (19.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,999 | $992,963 | |
| 2 | TECH |
BIO-TECHNE Corp
|
7,581 | $535,597 | |
| 3 | INCY |
Incyte Corp
This page
|
3,844 | $435,755 | |
| 4 | BMRN |
Biomarin Pharmaceutical Inc
|
4,378 | $250,509 | |
| 5 | AVXL |
Anavex Life Sciences Corp.
|
18,839 | $48,793 | |
| 6 | DRMA |
Dermata Therapeutics, Inc.
|
10,000 | $12,900 |
All Filings in INCY
Export CSV
10 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $435,755 | 3,844 | Shares | Sole | 2026-08-11 | |
| 2026-03-31 | $398,598 | 4,235 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $556,371 | 5,633 | Shares | Sole | 2026-02-06 | |
| 2025-09-30 | $509,368 | 6,006 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $481,671 | 7,073 | Shares | Sole | 2025-08-01 | |
| 2025-03-31 | $487,790 | 8,056 | Shares | Sole | 2025-05-19 | |
| 2024-12-31 | $544,962 | 7,890 | Shares | Sole | 2025-01-17 | |
| 2024-09-30 | $478,564 | 7,240 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $404,820 | 6,678 | Shares | Sole | 2024-08-21 | |
| 2024-03-31 | $319,943 | 5,616 | Shares | Sole | 2024-05-06 | |
| No filing history on record for this holder in this stock. | ||||||